Piper Sandler Companies (PIPR)
NYSE: PIPR
· Real-Time Price · USD
267.56
16.08 (6.39%)
At close: May 12, 2025, 2:37 PM
Piper Sandler Companies Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|
| Equity Sales and Trading Revenue | 215.28M | 209.51M | 210.31M | 154.07M | 161.44M |
| Equity Sales and Trading Revenue Growth | +2.75% | -0.38% | +36.51% | -4.57% | n/a |
| Fixed Income Sales and Trading Revenue | 186.17M | 168.03M | 194.95M | 233.51M | 196.31M |
| Fixed Income Sales and Trading Revenue Growth | +10.80% | -13.81% | -16.51% | +18.95% | n/a |
| Advisory Services Revenue | 808.75M | 709.32M | 776.43M | 1.03B | 443.33M |
| Advisory Services Revenue Growth | +14.02% | -8.64% | -24.33% | +131.46% | n/a |
| Corporate Financing Revenue | 173.88M | 131.08M | 125.34M | 362.8M | 295.33M |
| Corporate Financing Revenue Growth | +32.65% | +4.58% | -65.45% | +22.84% | n/a |
| Municipal Financing Revenue | 122.51M | 83.42M | 107.74M | 164.28M | 119.82M |
| Municipal Financing Revenue Growth | +46.86% | -22.57% | -34.42% | +37.11% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | n/a | 678.46M | 241.41M | 246.08M | 233.21M | 309.23M | 215.96M | 200.13M | 209.45M | 273.02M | 244.67M | 252.16M | 256.53M | 405.9M | 307.41M | 330.37M | 282.39M | 266.43M | 210.2M | 216.15M | 198.16M | 177.04M | 133.4M | 110.56M | 123.86M | 150.63M | 139.6M | 116.26M | 122.47M | 188.25M | 176.15M | 142.6M | 141.93M | 160.44M | 142.81M | 126.32M | 111.44M | 134.99M | 103.1M | 110.79M | 102.84M |
| Selling, General, and Administrative Revenue Growth | -100.00% | +181.04% | -1.90% | +5.52% | -24.58% | +43.19% | +7.91% | -4.45% | -23.28% | +11.59% | -2.97% | -1.71% | -36.80% | +32.04% | -6.95% | +16.99% | +5.99% | +26.75% | -2.75% | +9.08% | +11.93% | +32.72% | +20.65% | -10.74% | -17.77% | +7.90% | +20.07% | -5.07% | -34.95% | +6.87% | +23.53% | +0.47% | -11.54% | +12.34% | +13.06% | +13.35% | -17.45% | +30.94% | -6.95% | +7.73% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |